Biotechnology Stocks II Performance Guide: Nurix Therapeutics, Inc. (NRIX)
NRIX has no dividends.
Table and Chart of NRIX Performance
See what a $1,000 investment in NRIX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NRIX Returns | |
|---|---|
| Start Date | Aug-31-2020 |
| Start Price | $23.40 |
| End Date | May-16-2024 |
| End Price | $15.40 |
| # Prices | 46 |
| Min Date | Oct-31-2023 |
| Min Price | $5.59 |
| Max Date | Nov-30-2020 |
| Max Price | $42.62 |
| Total Return | -34.19% |
| Annualized Return | -10.34% |
| Current Value of $1,000 Purchase | $658 |
| Number Returns | 1,035 |
| Average Return | -32.70% |
| Number Profitable Returns | 183 |
| Percent Profitable Returns | 17.68% |
| Number Unprofitable Returns | 852 |
| Percent Unprofitable Returns | 82.32% |
| Profitable to Unprofitable Returns Ratio | 0.21 |
| NRIX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $970,973,000 |
| Beta | 2.104 | Price to Sales | 10.17 |
| Earnings per Share | $-2.6600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.876 |
| PRICE DATA | |
| 52 Week High | $18.12 |
| 52 Week Low | $4.22 |
| Analyst Target Price | $24.6 |
| 50-Day Moving Average | $14.08 |
| 200-Day Moving Average | $9.68 |
| FINANCIAL DATA | |
| Revenue per Share | $1.483 |
| Revenue | $80,887,000 |
| Profit Margin | -178.9% |
| Return on Equity | -65.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NRIX Compare Returns with S&P 500
NRIX Trendline Chart
NRIX Moving Average Chart
NRIX Stock Return Map - See Patterns of Gains and Losses
NRIX Stock Returns/Purchase Dates